Drug Discovery
AmberGen’s state-of-the-art MALDI Imaging facility provides label-free drug screening services based on its patented revolutionary Bead-AMS™ proteomic technology. This approach is especially useful to identify on and off-target hits against a library of proteins such as the kinome and can provide information about potential adverse drug side-effects and drug repurposing. Contact us to learn more.
Development of High-throughput, Accurate, Multiplex Immuno-Diagnostic Assays
AmberGen provides services to develop custom immunodiagnostics which incorporate our proprietary PC-PURE™ technology and bead-based automation methodology for gold-standard diagnostic performance and industry-leading throughput. Contact us to learn more.
Mass Spectrometric Imaging
AmberGen offers in-house mass spectrometric imaging services for advanced tissue and array scanning using state-of-the-art instruments and methodology to suit your research needs. Our experts will work with you to provide optimal research solutions. Contact us to learn more.
*Services to be launched in Q1 of 2017
Get in Touch with us!
Recent News
Recent Posts
- AmberGen receives US Patent 9,910,034 increasing its broad coverage on PC-PURE™ photo-affinity biomarker purification and enrichment technology for improving the accuracy of diagnostic testing March 2018
- Paper published in PLOS ONE in collaboration with Boston Children’s Hospital “Photocleavage-based affinity purification of biomarkers from serum: Application to multiplex allergy testing” describing application of AmberGen’s PC-PURE™ to highly multiplex in vitro allergy testing (AllerBead™) February 2018